{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:24:55Z","timestamp":1782311095129,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In response to the recent increase in measles cases and outbreaks across Europe, Czech surveillance data were analysed. The aim was also to evaluate the effect of vaccination on measles complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cases of measles reported to the national surveillance system according to the EU case definition (2018) between 2018\u20132024, were analysed. Demographic characteristics were assessed using descriptive analysis (counts and proportions). Logistic regression with an odds ratio (OR) supplemented with the 95% confidence interval (95% CI) was calculated to measure the association between vaccination status and the occurrence of complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 791 measles cases were reported during the study period, of which 762 (96%) were laboratory confirmed, 29 (4%) were probable and 416 (53%) were male. Most cases (546; 69%) occurred in 2019. Half of the cases (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009395, 50%) were outbreak related. The median age of cases was 33\u00a0years (range: 0\u201354). In total, 109 (14%) measles cases were imported (62 from Ukraine and smaller numbers from 25 other countries; 57 of the imported cases were unvaccinated) and 523 cases (70%) were hospitalised. In total, 330 (42%) of all cases were known to have been vaccinated, of which 205 (62%) with two or three doses and 75 (23%) with only one dose. Of 88 complications (11% of all cases) was pneumonia most frequent (n\u2009=\u200919; 2%). The highest proportion of complications occurred in infants (&lt;\u20091\u00a0year [too young to be vaccinated]; 28%) and in children aged 1\u20134\u00a0years (20%). Compared to unvaccinated cases, two and more vaccine doses significantly reduced odds of any complications (OR\u2009=\u20090.44, 95% CI: 0.24\u20130.81,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Within analysed 7-year period most cases were detected pre-pandemic in 2018 and 2019. It is likely that restrictive measures limited further epidemic potential. Isolation of measles case is mandatory in Czech Republic; therefore, this criterion does not reflect the clinical severity of cases. Having this limitation in mind, the effect of vaccination against measles complications only was demonstrated. To prevent further cases, increased awareness and promotion of measles vaccination is recommended for all individuals, including travellers, as a substantial proportion of cases were unvaccinated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-27042-8","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:55:50Z","timestamp":1774428950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Measles \u2013 retrospective study of cases reported in a national notification system, Czech Republic, 2018\u20132024"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8820-4239","authenticated-orcid":false,"given":"Monika","family":"Lipt\u00e1kov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6429-4023","authenticated-orcid":false,"given":"Marek","family":"Mal\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-1910","authenticated-orcid":false,"given":"Michaela","family":"\u0160pa\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7204-249X","authenticated-orcid":false,"given":"Radom\u00edra","family":"Limberkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lada","family":"Svobodov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0804-2729","authenticated-orcid":false,"given":"Jan","family":"Kyn\u010dl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"6","key":"27042_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12060696","volume":"12","author":"M Muscat","year":"2024","unstructured":"Muscat M, Ben Mamou M, de Reynen- Kat C, Jankovic D, Hagan J, Singh S, et al. Progress and challenges in measles and rubella elimination in the WHO European region. Vaccines. 2024;12(6):696. https:\/\/doi.org\/10.3390\/vaccines12060696.","journal-title":"Vaccines"},{"issue":"4","key":"27042_CR2","first-page":"184","volume":"18","author":"R Limberkov\u00e1","year":"2024","unstructured":"Limberkov\u00e1 R, Lipt\u00e1kov\u00e1 M, Man\u010f\u00e1kov\u00e1 Z, Svobodov\u00e1 L, Kyn\u010dl J. Measles\u2013situation in the Czech Republic and in the world in the context of the current unfavourable epidemiological situation. Vaccinology. 2024;18(4):184\u201392 (in Czech).","journal-title":"Vaccinology"},{"key":"27042_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coviro.2020.05.009","volume":"40","author":"L Yang","year":"2020","unstructured":"Yang L, Grenfell BT, Mina MJ. Waning immunity and re-emergence of measles and mumps in the vaccine era. Curr Opin Virol. 2020;40:48\u201354. https:\/\/doi.org\/10.1016\/j.coviro.2020.05.009.","journal-title":"Curr Opin Virol"},{"key":"27042_CR4","unstructured":"World Health Organization. European Region reports highest number of measles cases in more than 25 years \u2013 UNICEF, WHO\/Europe. Available from: https:\/\/www.who.int\/europe\/news\/item\/13-03-2025-european-region-reports-highest-number-of-measles-cases-in-more-than-25-years---unicef--who-europe. Cited 2026 Jan 30."},{"key":"27042_CR5","unstructured":"European Centre for Disease Prevention and Control. Measles - Annual epidemiological report for 2024. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/measles-annual-epidemiological-report-2024. Cited 2025 Sep 3."},{"key":"27042_CR6","unstructured":"European Centre for Disease Prevention and Control. Threat assessment brief: Measles on the rise in the EU\/EEA - Considerations for public health response. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/threat-assessment-brief-measles-rise-eueea-considerations-public-health-response. Cited 2026 Jan 30."},{"key":"27042_CR7","unstructured":"World Health Organization. Immunization data portal. Available from: https:\/\/immunizationdata.who.int\/. Cited 2026 Jan 30."},{"key":"27042_CR8","unstructured":"World Health Organization. Half a million children in WHO European Region not fully vaccinated in their first year of life: New 2023 data reveal both gaps and gains in immunization coverage. Available from: https:\/\/www.who.int\/europe\/news\/item\/15-07-2024-half-a-million-children-in-who-european-region-not-fully-vaccinated-in-their-first-year-of-life--new-2023-data-reveal-both-gaps-and-gains-in-immunization-coverage. Cited 2026 Jan 30."},{"key":"27042_CR9","unstructured":"World Health Organization. Childhood vaccination rates lag in Europe \u2013 fueling further resurgence of measles and whooping cough. Available from: https:\/\/www.who.int\/europe\/news\/item\/15-07-2025-childhood-vaccination-rates-lag-in-europe---fueling-further-resurgence-of-measles-and-whooping-cough. Cited 2026 Jan 30."},{"issue":"2","key":"27042_CR10","first-page":"54","volume":"17","author":"J Dlh\u00fd","year":"2023","unstructured":"Dlh\u00fd J, Kysel\u00fd Z, Ciupek R. Administrative estimates of vaccination coverage in children, the Czech Republic. Vaccinology. 2023;17(2):54\u201362 (in Czech).","journal-title":"Vaccinology"},{"key":"27042_CR11","unstructured":"The National Institute of Public Health. Measles - history of vaccination. Available from: https:\/\/szu.cz\/tema\/a-z-infekce\/s\/spalnicky\/spalnicky-historie-vakcinace\/. (in Czech). Cited 2025 Sep 3."},{"key":"27042_CR12","unstructured":"Ministry of Health of the Czech Republic. Act No. 258\/2000 Coll., on the protection of public health and on the amendment with some related Acts. 2000. (in Czech)."},{"key":"27042_CR13","unstructured":"Czech Statistical Office. Mid-year population 2018\u20132022. Available from: https:\/\/vdb.czso.cz\/vdbvo2\/faces\/en\/index.jsf?page=vystup-objekt-vyhledavani&vyhltext=obyvatelstvo&bkvt=b2J5dmF0ZWxzdHZv&pvo=DEM001D320201&z=T&f=TABULKA&katalog=all&c=v33~3__RP2022&&u=v1328__VUZEMI__97__19&str=v1328. (in Czech). Cited 2025 Sep 3."},{"issue":"1","key":"27042_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2307\/2336755","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80(1):27\u201338. https:\/\/doi.org\/10.2307\/2336755.","journal-title":"Biometrika"},{"issue":"1","key":"27042_CR15","first-page":"26","volume":"34","author":"H Bend\u00edkov\u00e1","year":"2025","unstructured":"Bend\u00edkov\u00e1 H. Experience from the local measles outbreak in the South Bohemian region. Zpr\u00e1vy CEM. 2025;34(1):26\u20138 (in Czech).","journal-title":"Zpr\u00e1vy CEM"},{"issue":"29","key":"27042_CR16","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.29.1900041","volume":"24","author":"M Lazar","year":"2019","unstructured":"Lazar M, St\u0103nescu A, Penedos AR, Pistol A. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania. Euro Surveill. 2019;24(29):1900041. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.29.1900041.","journal-title":"Euro Surveill"},{"issue":"37","key":"27042_CR17","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.37.30614","volume":"22","author":"A Filia","year":"2017","unstructured":"Filia A, Bella A, Del Manso M, Baggieri M, Magurano F, Rota MC. Ongoing outbreak with well over 4,000 measles cases in Italy from January to end August 2017 - what is making elimination so difficult? Euro Surveill. 2017;22(37):30614. https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.37.30614.","journal-title":"Euro Surveill"},{"key":"27042_CR18","unstructured":"Plotkin SA, Orenstein W, Offit PA. Vaccines. Elsevier Health Sciences. 2008."},{"issue":"3","key":"27042_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/cid\/ciae470","volume":"80","author":"J Leung","year":"2025","unstructured":"Leung J, Munir NA, Mathis AD, Filardo TD, Rota PA, Sugerman DE, et al. The effects of vaccination status and age on clinical characteristics and severity of measles cases in the United States in the postelimination era, 2001-2022. Clin Infect Dis. 2025;80(3):663\u201372. https:\/\/doi.org\/10.1093\/cid\/ciae470.","journal-title":"Clin Infect Dis"},{"issue":"10111","key":"27042_CR20","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","volume":"390","author":"WJ Moss","year":"2017","unstructured":"Moss WJ. Measles. Lancet. 2017;390(10111):2490\u2013502. https:\/\/doi.org\/10.1016\/S0140-6736(17)31463-0.","journal-title":"Lancet"},{"key":"27042_CR21","unstructured":"Filardo TD, Mathis A, Raines K, Masters NB, Rau A, Crooke SN, et al. Measles [chapter 7]. In: Roush SW, Baldy LM, editors. Manual for the surveillance of vaccine-preventable diseases. Available from: https:\/\/www.cdc.gov\/surv-manual\/php\/table-of-contents\/chapter-7-measles.html. Cited 2025 Sep 3."},{"key":"27042_CR22","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820000278","volume":"148","author":"L Cornelissen","year":"2020","unstructured":"Cornelissen L, Grammens T, Leenen S, Schirvel C, Hutse V, Demeester R, et al. High number of hospitalisations and non-classical presentations: lessons learned from a measles outbreak in 2017, Belgium. Epidemiol Infect. 2020;148:e35. https:\/\/doi.org\/10.1017\/S0950268820000278.","journal-title":"Epidemiol Infect"},{"issue":"17","key":"27042_CR23","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1016\/j.vaccine.2023.03.043","volume":"41","author":"C Stein-Zamir","year":"2023","unstructured":"Stein-Zamir C, Shoob H, Abramson D. Measles clinical presentation, hospitalization and vaccination status among children in a community-wide outbreak. Vaccine. 2023;41(17):2764\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.043.","journal-title":"Vaccine"},{"key":"27042_CR24","unstructured":"Ministry of Health of the Czech Republic, Decree No. 389\/2023 Coll., on Epidemiological surveillance system of selected infectious diseases. 2023. (in Czech)."},{"issue":"10","key":"27042_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/v13101982","volume":"13","author":"N L\u00f3pez-Perea","year":"2021","unstructured":"L\u00f3pez-Perea N, Fern\u00e1ndez-Garc\u00eda A, Echevarr\u00eda JE, de Ory F, P\u00e9rez-Olmeda M, Masa-Calles J. Measles in vaccinated people: epidemiology and challenges in surveillance and diagnosis in the post-elimination phase. Spain, 2014-2020. Viruses. 2021;13(10):1982. https:\/\/doi.org\/10.3390\/v13101982.","journal-title":"Viruses"},{"issue":"8","key":"27042_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/23744235.2024.2339870","volume":"56","author":"D Sm\u00ed\u0161kov\u00e1","year":"2024","unstructured":"Sm\u00ed\u0161kov\u00e1 D, Janovic S, Kade\u0159\u00e1vkov\u00e1 P, Nov\u00e1kov\u00e1 L, Blechov\u00e1 Z, Mal\u00fd M, et al. Measles in Czech population with varying vaccination rates in 2018\u20132019: clinical and laboratory differences between vaccinated and unvaccinated individuals and their relevance to clinical practice. Infect Dis. 2024;56(8):616\u201323. https:\/\/doi.org\/10.1080\/23744235.2024.2339870.","journal-title":"Infect Dis"},{"issue":"39","key":"27042_CR27","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1016\/j.vaccine.2023.08.018","volume":"41","author":"L Franconeri","year":"2023","unstructured":"Franconeri L, Antona D, Cauchemez S, L\u00e9vy-Bruhl D, Paireau J. Two-dose measles vaccine effectiveness remains high over time: a French observational study, 2017-2019. Vaccine. 2023;41(39):5797\u2013804. https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.018.","journal-title":"Vaccine"},{"issue":"7","key":"27042_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/infdis\/jiac039","volume":"226","author":"S Bolotin","year":"2022","unstructured":"Bolotin S, Osman S, Hughes SL, Ariyarajah A, Tricco AC, Khan S, et al. In elimination settings, measles antibodies wane after vaccination but not after infection: a systematic review and meta-analysis. J Infect Dis. 2022;226(7):1127\u201339. https:\/\/doi.org\/10.1093\/infdis\/jiac039.","journal-title":"J Infect Dis"},{"key":"27042_CR29","volume-title":"Control of communicable diseases manual","author":"DL Heymann","year":"2022","unstructured":"Heymann DL. Control of communicable diseases manual. 21st ed. Washington: American Public Health Association; 2022.","edition":"21st ed"},{"key":"27042_CR30","unstructured":"B\u00edlkov\u00e1-Fr\u00e1nkov\u00e1 H, Kloudov\u00e1 A, Zelen\u00e1 H. Multipurpose serological survey (measles, mumps, pertussis, viral hepatitis type B) 2013, Czech Republic - final report, annex 1. Zpr\u00e1vy CEM. 2014;1\u2013152. (in Czech)."},{"issue":"24","key":"27042_CR31","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1056\/NEJMra2504516","volume":"393","author":"LAH Do","year":"2025","unstructured":"Do LAH, Mulholland K. Measles 2025. N Engl J Med. 2025;393(24):2447\u201358. https:\/\/doi.org\/10.1056\/NEJMra2504516.","journal-title":"N Engl J Med"},{"issue":"5","key":"27042_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.7883\/yoken.65.371","volume":"65","author":"YJ Choe","year":"2012","unstructured":"Choe YJ, Hu JK, Song KM, Cho H, Yoon HS, Kim ST, et al. Evaluation of an expanded case definition for vaccine-modified measles in a school outbreak in South Korea in 2010. Jpn J Infect Dis. 2012;65(5):371\u20135. https:\/\/doi.org\/10.7883\/yoken.65.371.","journal-title":"Jpn J Infect Dis"},{"issue":"4","key":"27042_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf188","volume":"12","author":"CS Lutz","year":"2025","unstructured":"Lutz CS, Nguyen HQ, McClure DL, Masters NB, Chen MH, Colley H, et al. Patterns of decline in measles, mumps, and rubella neutralizing antibodies and protection levels through 10 years after a second and third dose of MMR vaccine. Open Forum Infect Dis. 2025;12(4):ofaf188. https:\/\/doi.org\/10.1093\/ofid\/ofaf188.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"27042_CR34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/infdis\/jiv555","volume":"213","author":"AP Fiebelkorn","year":"2016","unstructured":"Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, et al. Measles virus neutralizing antibody response, cell-mediated immunity, and immunoglobulin G antibody avidity before and after receipt of a third dose of measles, mumps, and rubella vaccine in young adults. J Infect Dis. 2016;213(7):1115\u201323. https:\/\/doi.org\/10.1093\/infdis\/jiv555.","journal-title":"J Infect Dis"},{"issue":"1","key":"27042_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad700","volume":"11","author":"OD Alonge","year":"2024","unstructured":"Alonge OD, Marin M, Hickman CJ, Sowers SB, Chen MH, Hao L, et al. Long-term neutralizing antibody levels against measles and rubella viruses among adults with 3 doses of measles-mumps-rubella vaccine. Open Forum Infect Dis. 2024;11(1):ofad700. https:\/\/doi.org\/10.1093\/ofid\/ofad700.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"27042_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2991\/jegh.k.191007.001","volume":"9","author":"WY Leong","year":"2019","unstructured":"Leong WY, Wilder-Smith AB. Measles resurgence in Europe: migrants and travellers are not the main drivers. J Epidemiol Glob Health. 2019;9(4):294\u20139. https:\/\/doi.org\/10.2991\/jegh.k.191007.001.","journal-title":"J Epidemiol Glob Health"},{"key":"27042_CR37","unstructured":"World Health Organization. Targeted and selective strategies in measles and rubella vaccination campaigns. Interim guidance. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240103399. Cited 2025 Sep 3."},{"issue":"12","key":"27042_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17124219","volume":"17","author":"J Malinov\u00e1","year":"2020","unstructured":"Malinov\u00e1 J, Petr\u00e1\u0161 M, \u010celko AM. A serosurvey identifying vulnerability to measles in health care workers. A hospital-based prospective seroprevalence study. Int J Environ Res Public Health. 2020;17(12):4219. https:\/\/doi.org\/10.3390\/ijerph17124219.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"27042_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170257","volume":"12","author":"J Smetana","year":"2017","unstructured":"Smetana J, Chlibek R, Hanovcova I, Sosovickova R, Smetanova L, Gal P. Decreasing seroprevalence of measles antibodies after vaccination - possible gap in measles protection in adults in the Czech Republic. PLoS ONE. 2017;12(1):e0170257. https:\/\/doi.org\/10.1371\/journal.pone.0170257.","journal-title":"PLoS ONE"},{"issue":"14","key":"27042_CR40","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.vaccine.2020.02.067","volume":"38","author":"L \u0160t\u011bp\u00e1nek","year":"2020","unstructured":"\u0160t\u011bp\u00e1nek L, Nakl\u00e1dalov\u00e1 M, Borikov\u00e1 A, Hor\u00e1kov\u00e1 D, \u0160t\u011bp\u00e1nek L. Measles immunity in a Czech tertiary care hospital. Vaccine. 2020;38(14):2889\u201392. https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.067.","journal-title":"Vaccine"},{"issue":"1","key":"27042_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21101\/cejph.a5251","volume":"26","author":"H Tom\u00e1\u0161kov\u00e1","year":"2018","unstructured":"Tom\u00e1\u0161kov\u00e1 H, Zelen\u00e1 H, Kloudov\u00e1 A, Tom\u00e1\u0161ek I. Serological survey of measles immunity in the Czech Republic, 2013. Cent Eur J Public Health. 2018;26(1):22\u20137. https:\/\/doi.org\/10.21101\/cejph.a5251.","journal-title":"Cent Eur J Public Health"},{"issue":"16","key":"27042_CR42","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2025.30.16.2400684","volume":"30","author":"DN Springer","year":"2025","unstructured":"Springer DN, Borsodi C, Camp JV, Redlberger-Fritz M, Holzmann H, Kundi M, et al. Seroprevalence against measles, Austria, stratified by birth years 1922 to 2024. Euro Surveill. 2025;30(16):2400684. https:\/\/doi.org\/10.2807\/1560-7917.ES.2025.30.16.2400684.","journal-title":"Euro Surveill"},{"key":"27042_CR43","unstructured":"Klechov\u00e1 A, \u0160anca O, Klika P, Klime\u0161 D, Mu\u017e\u00edk J, Komenda M, et al. Overview of vaccination coverage for selected vaccines within regions and districts of the Czech Republic. Available from: https:\/\/www.nzip.cz\/data\/1703-proockovanost-kraje-okresy-datovy-souhrn. (in Czech). Cited 2025 Sep 3."},{"key":"27042_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100128","volume":"7","author":"N Friedrich","year":"2021","unstructured":"Friedrich N, Poethko-M\u00fcller C, Kuhnert R, Matysiak-Klose D, Koch J, Wichmann O, et al. Seroprevalence of measles-, mumps-, and rubella-specific antibodies in the German adult population - cross-sectional analysis of the German health interview and examination survey for adults (DEGS1). Lancet Reg Health Eur. 2021;7:100128. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100128.","journal-title":"Lancet Reg Health Eur"},{"issue":"11","key":"27042_CR45","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1128\/CVI.00406-12","volume":"19","author":"S Mercader","year":"2012","unstructured":"Mercader S, Garcia P, Bellini WJ. Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings. Clin Vaccine Immunol. 2012;19(11):1810\u20137. https:\/\/doi.org\/10.1128\/CVI.00406-12.","journal-title":"Clin Vaccine Immunol"},{"key":"27042_CR46","unstructured":"European Centre for Disease Prevention and Control. Measles on the rise again in Europe: time to check your vaccination status. Available from: https:\/\/www.ecdc.europa.eu\/en\/news-events\/measles-rise-again-europe-time-check-your-vaccination-status. Cited 2026 Feb 2."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27042-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27042-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27042-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:50:27Z","timestamp":1781643027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27042-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27042"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27042-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the National Institute of Public Health (NIPH) approved the study (SZU\/05175\/2025) and our research had been performed in accordance with the declaration of Helsinki. Informed consent of the subject whose data were analysed is not required as all data were obtained from the routine surveillance system.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1451"}}